Cargando…

In silico exploration of disulfide derivatives of Ferula foetida oleo-gum (Covexir®) as promising therapeutics against SARS-CoV-2

Although vaccines have been significantly successful against coronavirus, due to the high rate of the Omicron variant spread many researchers are trying to find efficient drugs against COVID-19. Herein, we conducted a computational study to investigate the binding mechanism of four potential inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashemzadeh, Hassan, Iranshahy, Milad, Iranshahi, Mehrdad, Raissi, Heidar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112615/
https://www.ncbi.nlm.nih.gov/pubmed/35598351
http://dx.doi.org/10.1016/j.compbiomed.2022.105566
_version_ 1784709446757253120
author Hashemzadeh, Hassan
Iranshahy, Milad
Iranshahi, Mehrdad
Raissi, Heidar
author_facet Hashemzadeh, Hassan
Iranshahy, Milad
Iranshahi, Mehrdad
Raissi, Heidar
author_sort Hashemzadeh, Hassan
collection PubMed
description Although vaccines have been significantly successful against coronavirus, due to the high rate of the Omicron variant spread many researchers are trying to find efficient drugs against COVID-19. Herein, we conducted a computational study to investigate the binding mechanism of four potential inhibitors (including disulfide derivatives isolated from Ferula foetida) to SARS-CoV-2 main protease. Our findings revealed that the disulfides mainly interacted with HIS41, MET49, CYS145, HIS64, MET165, and GLN189 residues of SARS-CoV-2 main protease. The binding free energy decomposition results also showed that the van der Waals (vdW) energy plays the main role in the interaction of HIS41, MET49, CYS145, HIS64, MET165, and GLN189 residues with the inhibitors. Furthermore, it is found that the Z-isomer derivatives have a stronger interaction with SARS-CoV-2, and the strongest interaction belongs to the (Z)-1-(1-(methylthio)propyl)-2-(prop-1-enyl)disulfane (ΔG = −18.672 kcal/mol). The quantum mechanical calculations demonstrated that the second-order perturbation stabilization energy and the electron density values for MET49-ligand interactions are higher than the other residue-ligand complexes. This finding confirms the stronger interaction of this residue with the ligands.
format Online
Article
Text
id pubmed-9112615
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-91126152022-05-17 In silico exploration of disulfide derivatives of Ferula foetida oleo-gum (Covexir®) as promising therapeutics against SARS-CoV-2 Hashemzadeh, Hassan Iranshahy, Milad Iranshahi, Mehrdad Raissi, Heidar Comput Biol Med Article Although vaccines have been significantly successful against coronavirus, due to the high rate of the Omicron variant spread many researchers are trying to find efficient drugs against COVID-19. Herein, we conducted a computational study to investigate the binding mechanism of four potential inhibitors (including disulfide derivatives isolated from Ferula foetida) to SARS-CoV-2 main protease. Our findings revealed that the disulfides mainly interacted with HIS41, MET49, CYS145, HIS64, MET165, and GLN189 residues of SARS-CoV-2 main protease. The binding free energy decomposition results also showed that the van der Waals (vdW) energy plays the main role in the interaction of HIS41, MET49, CYS145, HIS64, MET165, and GLN189 residues with the inhibitors. Furthermore, it is found that the Z-isomer derivatives have a stronger interaction with SARS-CoV-2, and the strongest interaction belongs to the (Z)-1-(1-(methylthio)propyl)-2-(prop-1-enyl)disulfane (ΔG = −18.672 kcal/mol). The quantum mechanical calculations demonstrated that the second-order perturbation stabilization energy and the electron density values for MET49-ligand interactions are higher than the other residue-ligand complexes. This finding confirms the stronger interaction of this residue with the ligands. Elsevier Ltd. 2022-07 2022-05-17 /pmc/articles/PMC9112615/ /pubmed/35598351 http://dx.doi.org/10.1016/j.compbiomed.2022.105566 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Hashemzadeh, Hassan
Iranshahy, Milad
Iranshahi, Mehrdad
Raissi, Heidar
In silico exploration of disulfide derivatives of Ferula foetida oleo-gum (Covexir®) as promising therapeutics against SARS-CoV-2
title In silico exploration of disulfide derivatives of Ferula foetida oleo-gum (Covexir®) as promising therapeutics against SARS-CoV-2
title_full In silico exploration of disulfide derivatives of Ferula foetida oleo-gum (Covexir®) as promising therapeutics against SARS-CoV-2
title_fullStr In silico exploration of disulfide derivatives of Ferula foetida oleo-gum (Covexir®) as promising therapeutics against SARS-CoV-2
title_full_unstemmed In silico exploration of disulfide derivatives of Ferula foetida oleo-gum (Covexir®) as promising therapeutics against SARS-CoV-2
title_short In silico exploration of disulfide derivatives of Ferula foetida oleo-gum (Covexir®) as promising therapeutics against SARS-CoV-2
title_sort in silico exploration of disulfide derivatives of ferula foetida oleo-gum (covexir®) as promising therapeutics against sars-cov-2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112615/
https://www.ncbi.nlm.nih.gov/pubmed/35598351
http://dx.doi.org/10.1016/j.compbiomed.2022.105566
work_keys_str_mv AT hashemzadehhassan insilicoexplorationofdisulfidederivativesofferulafoetidaoleogumcovexiraspromisingtherapeuticsagainstsarscov2
AT iranshahymilad insilicoexplorationofdisulfidederivativesofferulafoetidaoleogumcovexiraspromisingtherapeuticsagainstsarscov2
AT iranshahimehrdad insilicoexplorationofdisulfidederivativesofferulafoetidaoleogumcovexiraspromisingtherapeuticsagainstsarscov2
AT raissiheidar insilicoexplorationofdisulfidederivativesofferulafoetidaoleogumcovexiraspromisingtherapeuticsagainstsarscov2